ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NIH awards Feinstein Institutes $2 million to study impact of heat, stroke on people with Alzheimer’s disease

Vulnerable populations, particularly those with Alzheimer’s disease and related dementias (ADRD), may experience greater health disparities due to the combined impact of socioeconomic stressors and their pre-existing cognitive impairments. These individuals are also known to be at even greater risk due to rising temperatures. To better investigate the impact of heat on stroke outcomes, particularly in this high-risk group, researchers at Northwell Health’s The Feinstein Institutes for Medical Research have been awarded a $2 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250416143257/en/

Drs. Pina C. Sanelli and Jason J. Wang are leading the study. (Credit: Feinstein Institutes).

Drs. Pina C. Sanelli and Jason J. Wang are leading the study. (Credit: Feinstein Institutes).

The research, led by Pina C Sanelli, MD, MPH, and Jason J Wang, PhD, will leverage a decade of data from a diverse patient population in the New York metropolitan region. The team will analyze acute ischemic stroke rates and trends, comparing neighborhoods with high and low heat vulnerability index (HVI) scores. The HVI integrates environmental heat and socioeconomic stressors to assess mortality risk. The study will also assess stroke severity upon hospital presentation and evaluate short-term outcomes such as in-hospital mortality and functional disability.

“This grant allows us to explore the intersection of environmental, socioeconomic, and health factors influencing stroke outcomes,” said Dr. Sanelli, professor, Institute of Health System Science at the Feinstein Institutes. “Our goal is to identify actionable strategies to mitigate these risks and improve the lives of vulnerable individuals.”

Environmental heat and socioeconomic stressors worsen both Alzheimer’s Disease (AD) and stroke, independently. People with AD are already at higher risk for stroke and experience worse stroke outcomes. However, no research has examined the combined effect of heat and socioeconomic hardship (i.e., heat vulnerability) on stroke outcomes in people with AD. This is important because poor stroke recovery, especially problems like dependent disability and swallowing difficulties, drastically reduces quality of life for those with AD. Therefore, it’s urgent to understand how heat vulnerability contributes to health disparities in stroke outcomes for this population.

“Preliminary data suggest a strong correlation between high heat vulnerability and increased stroke rates and severity,” explained Dr. Wang. “This research will delve deeper into these connections, examining the physiological mechanisms at play and the disproportionate impact on individuals with ADRD.”

A paper published last year by the team in the International Journal of Environmental Research and Public Health supports these initial findings.

“The link between extreme heat and stroke risk is a growing concern, particularly for those with cognitive impairments,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. “This funding allows our researchers to explore innovative approaches to mitigate this risk and pave the way for a healthier future for this vulnerable population.”

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50+ research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its six institutes of behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. We are the global scientific leader in bioelectronic medicine – an innovative field of science that has the potential to revolutionize medicine. The Feinstein Institutes publishes two open-access, international peer-reviewed journals Molecular Medicine and Bioelectronic Medicine. Through the Elmezzi Graduate School of Molecular Medicine, we offer an accelerated PhD program. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.